Anticoagulation Therapy

By:

Ozcan Basaran

Contributor(s):

Murat Biteker

Material type: Text

TextLanguage: English Publication details: New York: BoD – Books on Demand, c2016Description: 150 pagesISBN:

9789535126669
9535126660

Subject(s):

DDC classification:

Contents:

Contents: Comparative Biology of the Resistance to Vitamin The Risk Factors of Thrombogenic Thrombophilia and Management of Anticoagulation Around Cardiac Implantable Prothrombin Complex Concentrate a General Antidote for Oral NonVitamin K Antagonist Oral Anticoagulants in Atrial NonVitamin K Antagonist Oral Anticoagulants Clinical Use

Summary: The available parenteral and oral anticoagulants have a large clinical use. Understanding biochemistry of anticoagulants may help to improve therapeutic strategies. Resistance to vitamin K antagonist drugs might be a problem for rodent populations. Patients who have thrombogenic risk factors should be anticoagulated. The need for cardiac implantable electronic devices is increasing, and there is a substantial number of patients who are on oral anticoagulant therapy. Prothrombin complex concentrate and other plasma concentrates are useful to deal with over-coagulated situations. The efficacy and safety of non-vitamin K antagonist oral anticoagulants have been proven in large phase III trials. The real-world data suggest even better outcomes with these agents compared to vitamin K antagonists.

Item type: E-BOOKS

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Collection	Call number	Copy number	Status	Barcode
E-BOOKS	MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO	NFIC	615 (Browse shelf(Opens below))	EBS13766	-1	EBS13766

Total holds: 0

Browsing MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO shelves Close shelf browser (Hides shelf browser)

Previous								Next
Previous	615 Fundamentals of Toxicology Essential Concepts and Applications	615 Further MCQs in Pharmacy Practice	615 Antibiotics Targets, Mechanisms and Resistance	615 Anticoagulation Therapy	615 BNF Bnf for Children 2014-2015 British National Formulary for Children	615 FAC Drug Facts and Comparisons 2007 Drug Facts and Comparisons	615 FAC Drug Facts and Comparisons 2010 Drug Facts and Comparisons	Next

Contents:

Comparative Biology of the Resistance to Vitamin

The Risk Factors of Thrombogenic Thrombophilia and

Management of Anticoagulation Around Cardiac Implantable

Prothrombin Complex Concentrate a General Antidote for Oral

NonVitamin K Antagonist Oral Anticoagulants in Atrial

NonVitamin K Antagonist Oral Anticoagulants Clinical Use

The available parenteral and oral anticoagulants have a large clinical use. Understanding biochemistry of anticoagulants may help to improve therapeutic strategies. Resistance to vitamin K antagonist drugs might be a problem for rodent populations. Patients who have thrombogenic risk factors should be anticoagulated. The need for cardiac implantable electronic devices is increasing, and there is a substantial number of patients who are on oral anticoagulant therapy. Prothrombin complex concentrate and other plasma concentrates are useful to deal with over-coagulated situations. The efficacy and safety of non-vitamin K antagonist oral anticoagulants have been proven in large phase III trials. The real-world data suggest even better outcomes with these agents compared to vitamin K antagonists.

There are no comments on this title.

to post a comment.